PLSE

Pulse Biosciences (PLSE)

Pulse Biosciences Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:PLSE

1 2 3 4 5 6 7 8 9 10 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/05/15	22:05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/15	05:05	Business Wire	Pulse Biosciences Enhances Executive Leadership Team	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/09	22:09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/09	21:00	Business Wire	Pulse Biosciences Announces First U.S. Procedure with the CellFX nsPFA Percutaneous Electrode System	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/08	05:18	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/08	05:14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/08	05:05	Business Wire	Pulse Biosciences Reports Business Updates and First Quarter 2024 Financial Results	NASDAQ:PLSE	Pulse Biosciences Inc
2024/05/02	21:00	Business Wire	Pulse Biosciences Announces Timing of Rights Offering for Up to $60,000,000	NASDAQ:PLSE	Pulse Biosciences Inc
2024/04/25	05:05	Business Wire	Pulse Biosciences Schedules First Quarter 2024 Financial Results Conference Call for May 7, 2024	NASDAQ:PLSE	Pulse Biosciences Inc
2024/03/29	05:12	Business Wire	Pulse Biosciences Reports Business Updates and Fourth Quarter & Full Year 2023 Financial Results	NASDAQ:PLSE	Pulse Biosciences Inc
2024/03/29	05:10	Business Wire	Pulse Biosciences Announces Plans to Initiate a Rights Offering	NASDAQ:PLSE	Pulse Biosciences Inc
2024/03/15	05:05	Business Wire	Pulse Biosciences Schedules Fourth Quarter & Full Year 2023 Financial Results Conference Call for March 28, 2024	NASDAQ:PLSE	Pulse Biosciences Inc
2024/03/11	22:10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/03/09	03:17	Business Wire	Pulse Biosciences Announces FDA 510(k) Clearance for its CellFX® nsPFA™ Percutaneous Electrode System	NASDAQ:PLSE	Pulse Biosciences Inc
2024/02/14	23:22	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/02/14	22:00	Business Wire	Pulse Biosciences Announces Positive 60-Day Follow-Up Evaluations for Initial Patients treated in the CellFX® nsPFA™ 360° Cardiac Catheter First-in-Human Feasibility Study	NASDAQ:PLSE	Pulse Biosciences Inc
2024/01/31	22:00	Business Wire	Pulse Biosciences Announces Preliminary Findings from its CellFX nsPFA 360 Cardiac Catheter First-In-Human Feasibility Study to be Featured in Podium Presentation at the AF Symposium	NASDAQ:PLSE	Pulse Biosciences Inc
2024/01/09	23:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/01/02	23:20	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2024/01/02	22:00	Business Wire	Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX® nsPFA™ Cardiac Clamp	NASDAQ:PLSE	Pulse Biosciences Inc
2023/12/22	23:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2023/12/20	23:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2023/12/20	22:00	Business Wire	Pulse Biosciences Announces First-in-Human Procedures with its Novel CellFX™ Nanosecond Pulsed Field Ablation (nsPFA™) Cardiac Catheter	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/28	07:29	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/27	23:08	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/21	23:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/21	22:00	Business Wire	Pulse Biosciences Files 510(k) Submission with U.S. FDA for its CellFX nsPFA Percutaneous Electrode	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/17	23:11	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/17	23:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:PLSE	Pulse Biosciences Inc
2023/11/16	06:05	Business Wire	Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference	NASDAQ:PLSE	Pulse Biosciences Inc